助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[114]条 当前为第1条到20条[由于搜索限制,当前仅支持显示前5页数据]
 

相关语句
treatment of schizophrenia
Cost-effectiveness studies in the treatment of schizophrenia: a review
      
Mental health laws that require dangerousness for involuntary admission may delay the initial treatment of schizophrenia
      
We reviewed the pharmacological properties of perospirone hydrochloride (perospirone), a novel atypical antipsychotic agent, and discussed the potential role of 5-HT2 and 5-HT1A receptors in its action for the treatment of schizophrenia.
      
Efficacy of second-generation antipsychotics in the treatment of schizophrenia
      
There are few data, however, comparing the overall efficacy of the firstline SGAs (aripiprazole, olanzapine, quetiapine, risperidone, and ziprasidone) in the treatment of schizophrenia and schizoaffective disorder.
      
Data thus far suggest that the first-line SGAs are of comparable efficacy in the treatment of schizophrenia and schizoaffective disorder.
      
In the area where perhaps heretofore there was the greatest divergence, emerging information suggests an overlap in therapeutic efficacy between medications used for the treatment of schizophrenia and those agents used for treating mood disorders.
      
This article reviews the recent developments in the treatment-emergent endocrine abnormalities in schizophrenia and points to relevant clinical implications for the treatment of schizophrenia.
      
Atypical antipsychotic medications have been approved for treatment of schizophrenia and broad efficacy has led to trials for other illnesses.
      
Best practice pharmacologic treatment of schizophrenia: Applying principles of evidence-based medicine
      
Although the neurotransmitter dopamine plays a prominent role in the treatment of schizophrenia, the dopamine hypothesis fails to explain several aspects of the disorder.
      
What have we learned from CATIE about the pharmacologic treatment of schizophrenia
      
Pharmacologic treatment of schizophrenia: Current status and future trends
      
The advent of the "atypical" antipsychotics has significantly advanced the pharmacologic treatment of schizophrenia and other psychotic disorders.
      
Current short-comings in the pharmacologic treatment of schizophrenia and strategies under investigation to address each of these deficiencies are reviewed.
      
Due to increased sophistication of neuropsychologic assessment and neuroimaging techniques, cognitive impairment has again has risen to the forefront of importance in terms of theories regarding the etiology and treatment of schizophrenia.
      
We review the six areas of evidence-based treatment of schizophrenia, as well as knowledge regarding implementation of mental health programs in routine practice settings.
      
Should the treatment of schizophrenia include old antipsychotic drugs
      
Traditional antipsychotics clearly still have a role in the treatment of schizophrenia and they remain the authors' preferred choice of first-line therapy.
      
Aripiprazole was recently approved for the treatment of schizophrenia by the US Food and Drug Administration in late 2002, and is being used increasingly in clinical settings.
      
 

首页上一页12345下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社